Improvement of Antibody Responses by HIV Envelope DNA and Protein Co-Immunization

BACKGROUND: Developing HIV Envelope (Env) vaccine components that elicit durable and protective antibody responses is an urgent priority, given the results from the RV144 trial. Optimization of both the immunogens and vaccination strategies will be needed to generate potent, durable antibodies. Due...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Pissani, Franco, Malherbe, Delphine C., Schuman, Jason T., Robins, Harlan, Park, Byung S., Krebs, Shelly J., Barnett, Susan W., Haigwood, Nancy L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3926420/
https://ncbi.nlm.nih.gov/pubmed/24280279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2013.11.022
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky